Fasting human pancreatic polypeptide (HPP) levels are similar in patients with type 2 diabetes, chronic pancreatitis, and pancreatic ductal adenocarcinoma, regardless of their glycemic status, according to a study published in Pancreas, making them an inadequate diagnostic biomarker.
Patients with diabetes that results from pancreatic disorders have been described by the term type 3c diabetes mellitus, and the condition is often misdiagnosed as type 2 diabetes. Read more . . .